In preclinical studies, treatment of CLL and AML cell cultures with TP-0903 resulted in decreased AXL phosphorylation and induction of apoptosis at concentrations achievable in vivo [61,81]. The gene discussed is AXL; the disease is acute myeloid leukemia.